Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer

NCT02980965 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

249

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Female

Interventions

DRUG: letrozole, leuprorelin, fluorouracil, epirubicin, cyclophosphamide, docetaxel
DRUG: fluorouracil, epirubicin, cyclophosphamide, docetaxel

Sponsor

Fudan University